Value and Implementation of the Aggregate Safety Assessment Plan

Area of Science:

• Pharmacovigilance and Drug Safety
• Regulatory Science
• Biostatistics

Background:

• Aggregate safety assessment is crucial for characterizing a product's safety profile.
• The Drug Information Association-American Statistical Association working group proposed an Aggregate Safety Assessment Plan (ASAP).
• ASAP aims for consistent data collection and analysis, minimizing missing data for regulatory submissions.

Purpose of the Study:

• To highlight the benefits and efficiencies of implementing an ASAP in drug development.
• To demonstrate how ASAP aids in optimally characterizing a product's emerging safety profile.
• To illustrate the practical application of ASAP using examples of Safety Topics of Interest (STOI).

Main Methods:

• Review of the Aggregate Safety Assessment Plan (ASAP) framework.
• Identification and definition of Safety Topics of Interest (STOI) within the ASAP.
• Case study analysis using two STOIs to showcase ASAP implementation.

Main Results:

• ASAP implementation leads to a consistent approach in safety data management.
• Identification of STOIs ensures focused data collection and analysis for potential risks.
• The study demonstrates significant benefits and efficiencies in safety planning and profile characterization.

Conclusions:

• The ASAP provides a structured framework for aggregate safety assessment in drug development.
• Effective identification and management of STOIs are critical for robust safety evaluations.
• Implementing ASAP enhances the ability to characterize a product's safety profile and supports regulatory submissions.